These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 20817387)

  • 1. [Pemphigus].
    Lapeyre-Liénard H; Joly P
    Presse Med; 2010 Oct; 39(10):1066-70. PubMed ID: 20817387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pemphigus.
    Schmidt E; Kasperkiewicz M; Joly P
    Lancet; 2019 Sep; 394(10201):882-894. PubMed ID: 31498102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment strategies for pemphigus vulgaris in Japan.
    Hashimoto T
    Expert Opin Pharmacother; 2008 Jun; 9(9):1519-30. PubMed ID: 18518782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of refractory childhood pemphgus vulgaris with anti-CD20 monoclonal antibody (rituximab).
    Kong HH; Prose NS; Ware RE; Hall RP
    Pediatr Dermatol; 2005; 22(5):461-4. PubMed ID: 16191003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term prognosis of pemphigus in Korea: retrospective analysis of 199 patients.
    Kim MR; Kim HC; Kim SC
    Dermatology; 2011; 223(2):182-8. PubMed ID: 22025028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Juvenile pemphigus vulgaris].
    Janisson-Dargaud D; Reguiaï Z; Perceau G; Eschard C; Bernard P
    Ann Dermatol Venereol; 2008 Dec; 135(12):843-7. PubMed ID: 19084695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The actual management of pemphigus.
    Daniel BS; Murrell DF
    G Ital Dermatol Venereol; 2010 Oct; 145(5):689-702. PubMed ID: 20930702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Paraneoplastic pemphigus].
    Preisz K; Kárpáti S
    Orv Hetil; 2007 May; 148(21):979-83. PubMed ID: 17513251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of pemphigus in pediatric patients.
    Gürcan H; Mabrouk D; Razzaque Ahmed A
    Minerva Pediatr; 2011 Aug; 63(4):279-91. PubMed ID: 21909064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral pemphigus.
    Mignogna MD; Fortuna G; Leuci S
    Minerva Stomatol; 2009 Oct; 58(10):501-18. PubMed ID: 19893475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [[Treatment of therapy resistant pemphigus vulgaris with rituximab and immunoglobulins].
    Mühlhoff C; Megahed M
    Hautarzt; 2007 Nov; 58(11):924-6. PubMed ID: 17952393
    [No Abstract]   [Full Text] [Related]  

  • 12. Pemphigus vulgaris: a short review for the practitioner.
    Guillen S; Khachemoune A
    Dermatol Nurs; 2007 Jun; 19(3):269-72. PubMed ID: 17626506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraneoplastic Pemphigus. A Life-Threatening Autoimmune Blistering Disease.
    Tirado-Sánchez A; Bonifaz A
    Actas Dermosifiliogr; 2017 Dec; 108(10):902-910. PubMed ID: 28801011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab in refractory pemphigus vulgaris.
    Sorce M; Aricò M; Bongiorno MR
    Dermatol Ther; 2008 Jul; 21 Suppl 1():S6-9. PubMed ID: 18727815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current therapy of the pemphigus group.
    Kasperkiewicz M; Schmidt E; Zillikens D
    Clin Dermatol; 2012; 30(1):84-94. PubMed ID: 22137231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin.
    Ahmed AR; Spigelman Z; Cavacini LA; Posner MR
    N Engl J Med; 2006 Oct; 355(17):1772-9. PubMed ID: 17065638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pemphigus in elderly adults: clinical presentation, treatment, and prognosis.
    Ingen-Housz-Oro S; Alexandre M; Le Roux-Villet C; Picard-Dahan C; Tancrède-Bohin E; Wallet-Faber N; Mahé E; Begon E; Francès C; Sigal M; Grootenboer-Mignot S; Aucouturier F; André C; Wolkenstein P; Chosidow O; Prost-Squarcioni C
    J Am Geriatr Soc; 2012 Jun; 60(6):1185-7. PubMed ID: 22690997
    [No Abstract]   [Full Text] [Related]  

  • 18. Rituximab treatment of pemphigus in women of childbearing age: experience with two patients.
    Lake EP; Huang YH; Aronson IK
    J Dermatolog Treat; 2017 Dec; 28(8):751-752. PubMed ID: 27796136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current treatment of autoimmune blistering diseases.
    Kasperkiewicz M; Schmidt E
    Curr Drug Discov Technol; 2009 Dec; 6(4):270-80. PubMed ID: 20025595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermediate doses of rituximab used as adjuvant therapy in refractory pemphigus.
    Londhe PJ; Kalyanpad Y; Khopkar US
    Indian J Dermatol Venereol Leprol; 2014; 80(4):300-5. PubMed ID: 25035353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.